Menu Close

Category: Daily News

AMA and 100 Provider Groups Fight Cigna Fee Schedule

The Cigna Group recently notified network providers that it will deny payment for Evaluation and Management (E/M) services reported with modifier 25 if records documenting a significant and separately identifiable service are not submitted with the claim. Modifier 25 records and bills for E/M service on the same day of another service or procedure when it is performed by the same physician or provider.

This triggered a contentious response from the American Medical Association (AMA) and more than 100 other provider trade associations who have taken issue with a new policy from Cigna regarding claims with modifier 25.

Evaluation and management (E/M) services represent a category of Current Procedural Terminology (CPT®) codes used for billing purposes. E&M coding involves use of CPT codes ranging from 99202 to 99499. Office visits, hospital visits, home services and preventive medicine services are considered E&M codes. Codes for procedures like surgeries, radiology and diagnostic tests, and certain treatment therapies are not considered evaluation and management services.

Current Procedural Terminology (CPT®) modifiers (also referred to as Level I modifiers) are used to supplement the information or adjust care descriptions to provide extra details concerning a procedure or service provided by a physician. Code modifiers help further describe a procedure code without changing its definition. Several of these modifiers have become topics of controversy between providers and payers.

Modifier 25 is used to facilitate billing of E/M services on the day of a procedure for which separate payment may be made. It is used to report a significant, separately identifiable E/M service by the same physician on the day of a procedure.

For example, modifier 25 may be used in the rare circumstance of an E/M service the day before a major operation and represents a significant, separately identifiable service; it likely would be associated with a different diagnosis (for example, evaluation of a cough that might affect the operation).

The Centers for Medicare & Medicaid Services (CMS) has identified the overuse and misuse of Current CPT® code modifier 25, and has taken regulatory action hoping to circumvent the problems it has identified. The 59 modifier is considered the most misused modifier by coders. It is normally used to indicate that two or more procedures were performed during the same visit to different sites on the body.

According to a report by  RevCycle Intelligence, the groups wrote in a letter to Cigna CEO David Cordani last week that the new policy is burdensome for providers even though they understand inappropriate use of modifier 25 should be prevented.

We urge Cigna to reconsider this policy due to its negative impact on practice administrative costs and burdens across medical specialties and geographic regions, as well as its potential negative effect on patients, and instead partner with our organizations on a collaborative educational initiative to ensure correct use of modifier 25,” they wrote in the letter.

The groups also said they questioned the standards or guidelines Cigna used to craft the new modifier 25 policy since the Current Procedural Terminology (CPT®) description states that modifier 25 enables reporting of a significant, separately identifiable E/M service by the same physician or other healthcare professional on the same day of a procedure or other service. The CPT code set was developed by the AMA.

CMS and CPT guidelines also indicate that an E/M service reported with a modifier 25 does not need a different diagnosis than what was reported for the concurrent procedure, which Cigna misinterpreted in its current modifier 25 policy, according to the letter.

Failing to rescind the policy would result in an enormous amount of office notes being sent with claims, which not only burdens network providers but also the insurer.

“Indeed, Cigna previously advised medical societies that only a small percentage (i.e., 10 percent) of submitted documentation would be reviewed under this program,” the groups explained. “This troubling admission demonstrates Cigna’s awareness of the unmanageable volume of records in question and, more importantly, highlights the pointless administrative waste created by the policy.”

Adding to data submission burdens is the lack of an electronic standard for clinical record exchange, the letter continued.

All of these concerns underscore that Cigna’s policy is extremely ill-timed and will further hamper health care professionals already grappling with clinician burnout, workforce shortages, recovery from the COVID-19 public health emergency, and rising practice expenses due to inflation,” the groups wrote.

The groups said they are willing to collaborate with Cigna to ensure the appropriate use of modifier 25, including doing targeted outreach and coding education. They also advised the insurer to limit documentation so that only network providers with consistent miscoding have to send office notes along with their claims.

Google AI Technology Passes US Medical License Exam

GPT stands for Generative Pre-trained Transformer (GPT), a type of language model that uses deep learning to generate human-like, conversational text. GPT-4 is the newest version of OpenAI’s language model systems. Its previous version, GPT 3.5, powered the company’s wildly popular ChatGPT chatbot when it launched in November of 2022.

Last month we reported that GPT-4, the new multimodal deep learning model from OpenAI, has passed the Uniform Bar Exam, demonstrating an enormous leap for machine learning and proving that an artificial intelligence program can perform complex legal tasks on par with or better than humans, according to a new paper co-authored by Daniel Martin Katz, professor of law at Illinois Institute of Technology’s Chicago-Kent College of Law.

And now Google has announced the latest version of Med-PaLM a large language model (LLM) designed to provide high quality answers to medical questions.

Med-PaLM harnesses the power of Google’s large language models, which have been aligned to the medical domain with a set of carefully-curated medical expert demonstrations.

Developing AI that can answer medical questions accurately has been a long-standing challenge with several research advances over the past few decades. While the topic is broad, answering US Medical License Exam (USMLE)-style questions has recently emerged as a popular benchmark for evaluating medical question answering performance.

Google’s first version of Med-PaLM, preprinted in late 2022, was the first AI system to surpass the pass mark on US Medical License Exam (USMLE) questions. Med-PaLM also generates accurate, helpful long-form answers to consumer health questions, as judged by panels of physicians and users.

Google introduced its latest model, Med-PaLM 2, at its annual health event The Check Up. Med-PaLM 2 achieves an accuracy of 85.4% on USMLE questions. This performance is on par with “expert” test takers, and is an 18% leap over its own state of the art results from Med-PaLM.

Google assessed Med-PaLM and Med-PaLM 2 against a benchmark it called ‘MultiMedQA’, which combines seven question answering datasets spanning professional medical exams, medical research, and consumer queries.

Med-PaLM was the first AI system to obtain a passing score on USMLE questions from the MedQA dataset, with an accuracy of 67.4%. Med-PaLM 2 improves on this further with state of the art performance of 85.4%, matching expert test-takers.

Google will soon release a preprint for Med-PaLM 2. In the coming months, Med-PaLM 2 will also be made available to a select group of Google Cloud customers for limited testing, to explore use cases and share feedback, as we investigate safe, responsible, and meaningful ways to use this technology.

Court Reinstates Billing Class Action Against Modesto Hospital

A California appeals court reinstated a class action against a medical center that allegedly violated unfair competition laws and consumer protections by charging emergency room patients an undisclosed “Evaluation and Management Services Fee.”

Joshua Naranjo filed a class action lawsuit against the Doctors Medical Center of Modesto Inc., seeking declaratory and injunctive relief, and alleging violations of the unfair competition law (UCL) and the Consumer Legal Remedies Act (CLRA) in connection with Medical Center’s emergency room billing practices.

Briefly summarized, Naranjo alleged Medical Center’s practice of charging him (and other similarly situated patients) an undisclosed “Evaluation and Management Services Fee” (EMS Fee) was an “unfair, deceptive, and unlawful practice.”

Naranjo alleged, “[Medical Center’s] summary billing statements are not itemized and do not list items separately.” As a result, “most emergency room patients never even realize they have been charged a separate EMS Fee, even after their visit.” “[E]ven for those patients who do request and receive an itemized billing statement, EMS Fees are listed only as ER ROOM LEVEL [I-V], which does not inform a patient that this is a separate charge simply for receiving treatment in the emergency room.”

Medical Center’s EMS Fee is “set at one of five levels, determined after discharge, based on an internally developed formula known exclusively to [Medical Center].” The “algorithm used to determine the level of the EMS Fee (1, 2, 3, 4, or 5) is not disclosed to patients, making it virtually impossible for patients to know or seek to control the level or amount of the EMS Fee they will be charged for their emergency room visit.”

Medical Center charged Naranjo a total of $12,889.93 before any discounts or adjustments were applied. The gross charge included a “Level 4” EMS Fee in the amount of $8,833.35.

Medical Center demurred to each cause of action alleged in the first amended complaints on grounds each failed to state facts sufficient to state a cause of action. It was granted, and judgment was entered against Naranjo and in favor of Medical Center. The Court of Appeal reversed in the published case of Naranjo v Doctors Medical Center of Modesto Inc. -F083197 (April 2023).

On appeal, Naranjo contends he adequately alleged claims for declaratory and injunctive relief, violation of the UCL, and violation of the CLRA. Alternatively, he contends he should have been granted leave to amend to add a claim for breach of contract.

Naranjo has adequately alleged a claim under the Consumer Legal Remedies Act (CLRA) (Civ. Code, § 1750 et seq.). Naranjo has alleged Medical Center’s EMS Fee billing practices were known exclusively to Medical Center and that information in that regard was not reasonably accessible to Naranjo. And Naranjo sufficiently alleged the materiality of the nondisclosure. Naranjo also sufficiently alleged reliance, causation and damages.

The Court of Appeal also concluded that his CLRA claim is independently actionable under the unfair competition law (UCL) and is tethered to the legislative policies underlying the CLRA.

Beverly Hills Surgeon Resolves Fraud Claims for $24 Million

A plastic surgeon in Beverly Hills, along with his son, medical practices and billing company, have agreed to pay $23.9 million to resolve allegations that they violated the False Claims Act by submitting or causing the submission of false claims to both Medicare and Medicaid.

The settlement resolves allegations that Dr. Joel Aronowitz; Daniel Aronowitz; Joel A. Aronowitz, M.D., a medical corporation; Tower Multi-Specialty Medical Group; Tower Wound Care Center of Santa Monica, Inc.; Tower Outpatient Surgery Center, Inc.; and Tower Medical Billing Solutions falsified the place of service for skin grafts and billed multiple times for single-use skin substitute products.

The United States contends that the settling parties manipulated the place of service code on claims for skin grafts to fraudulently maximize reimbursement from Medicare and Medicaid. The United States further contends that Dr. Aronowitz failed to properly dispose of unused portions of single-use skin graft materials and, instead, used them in later procedures involving other Medicare and Medicaid beneficiaries, resulting in thousands of instances of double billing.

In connection with the settlement, the United States Department of Health and Human Services, Office of Inspector General (HHS OIG), negotiated the voluntary exclusion of Dr. Aronowitz and Tower Multi-Specialty Medical Group from Medicare, Medicaid, and all other federal health care programs for a period of 15 years. Daniel Aronowitz will be excluded for three years.

Medicaid is funded jointly by the states and the federal government. The state of California paid for a portion of the Medicaid claims at issue and will receive a total of approximately $497,619 from the settlement.

The civil settlement includes the resolution of claims brought under the qui tam, or whistleblower, provisions of the False Claims Act by parties that worked for Dr. Aronowitz and his associated medical practices and businesses: TDP, a billing company; Dr. Jason Morris, a podiatrist; and Harold Bautista, a billing department employee.

Under the qui tam provisions, a private party can file an action on behalf of the government and receive a portion of any recovery. The civil lawsuits, all of which were filed in federal court in Los Angeles, are captioned: United States ex rel. TDP RCM Servs., LLC v. Aronowitz, et al., United States ex rel. Morris, et al. v. Tower Wound Care Ctr. of Santa Monica, Inc., et al., and United States ex rel. Bautista et al. v. Tower Outpatient Surgery Center, Inc., et al.. The amount to be recovered by the private parties has not been determined.

The resolution obtained in this matter was the result of a coordinated effort between the United States Attorney’s Office in Los Angeles and the United States Justice Department’s Civil Division, Commercial Litigation Branch, Fraud Section. HHS OIG assisted in the investigation.

The matter was handled by Assistant United States Attorney Aaron Ezroj of the Civil Fraud Section and Trial Attorney Lyle Gruby of the Justice Department’s Civil Division. The exclusions of the individuals and entity were negotiated by Senior Counsel Patrice Drew for HHS OIG.

The investigation and resolution of this matter illustrates the government’s emphasis on combating healthcare fraud. One of the most powerful tools in this effort is the False Claims Act. Tips and complaints from all sources about potential fraud, waste, abuse and mismanagement can be reported to the Department of Health and Human Services at 800-HHS-TIPS (800-447-8477).

The claims resolved by the settlement are allegations only and there has been no determination of liability.

Merced Family Charged in $2.1M Payroll Fraud Schemes

Following a Department of Insurance investigation, four Merced family members were arraigned this week for multiple counts of insurance fraud.

The investigation revealed the businesses owned and/or operated by these residents had allegedly underreported payroll by millions of dollars, leading to an illegal underpayment of over $2.1 million in workers’ compensation insurance premiums.

This alleged fraud was discovered after a previous Department of Insurance investigation which resulted in the sentencing of a father and daughter for a similar underreporting scheme. The daughter in that investigation, Angelita Barocio-Negrete, was also the office manager and bookkeeper for two additional family-owned farm labor contracting businesses in Merced County.

An investigation into these businesses revealed they too allegedly underreported payroll to their insurance carrier.

Between December 2007 and January 2013, Negrete M. Agriculture Inc., owned by Maria Negrete-Melchor, 55, and her daughter-in-law Melissa Bourbois, 39, had a workers’ compensation insurance policy issued by State Compensation Insurance Fund. Maria’s daughter, Angelita Barocio-Negrete, 36, was the office manager and bookkeeper. During this time, they reported $552,517 in payroll to State Fund.

A forensic audit revealed Negrete M. Agriculture Inc. actually had $4,026,125 in payroll, resulting in an underreporting of $3,473,608.

Between November 2012 and November 2015, Negrete & Son’s Ag Inc., owned by Albaro Barocio, 39, had a workers’ compensation insurance policy also issued by State Compensation Insurance Fund. Albaro’s sister, Angelita Barocio-Negrete, was the office manager and bookkeeper. During this time, the insured reported $654,091 in payroll to State Fund.

A forensic audit revealed Negrete & Son’s Ag Inc. actually had $4,679,409 in payroll, resulting in an underreporting of $4,025,317.

The underreporting by both companies resulted in a loss of $2,165,308 in premium by State Fund.

All four family members were arraigned on April 25, 2023. They are scheduled to return to court on August 1, 2023. The Merced County District Attorney’s Office is prosecuting this case.

Failure to Prove Regulatory Compliance Ends Employer Medical Control

In recent panel decisions the WCAB seems to be less forgiving of litigants who assert what seems to be obvious facts in a case, but then do not submit substantial evidence to prove their assertion. The lesson here it to make sure every essential detail needed to win an issue has been meticulously documented and proven at trial.

In this case, Sherrill Claytor was injured on June 12, 2014 while employed as a doctor’s assistant by Alexander T. Latteri, M.D. She treated with Dr. Spencer as her PTP from 2014 to 2019.

On September 3, 2019, Claytor sent State Fund a letter selecting Scott Small, M.D. as her PTP and request to change her PTP. Dr. Small provided treatment to her from 2019 into 2020 and she also continued to receive treatment from Dr. Spencer from July 2019 to at least December 2019 while also treating with Dr. Small.

On June 1, 2020, Claytor sent a letter to SCIF requesting to treat with Dr. Spencer as her PTP again. On June 15, 2020, SCIF replied stating that it ended the contract with Harbor Health Systems as the MPN administrator of the State Fund MPN by Harbor Health effective July 27, 2020. But it also said that “State Fund will allow you to continue your treatment with your current primary treating physician, treating physicians and/or providers after July 27, 2020.”

The matter proceeded to trial on December 1, 2020 with the sole issue identified as: “Can the Applicant resume treatment with Dr. Spencer as the PTP outside of the MPN.” By the F&O, the WCJ found that applicant is permitted to treat with Dr. Curtis Spencer outside of defendant’s medical provider network (MPN).

The State Fund petition for Reconsideration was denied in the panel decision of Sherrill Claytor v SCIF – ADJ11059073 (January 2023).

If an employer has established an MPN, injured workers are generally limited to treating with a physician from within the employer’s MPN. However, if the employer neglects or refuses to provide reasonably necessary medical treatment, whether through an MPN or otherwise, then an injured worker may self-procure medical treatment at the employer’s expense.

The Appeals Board has held en banc that “a defendant may satisfy its obligation under Labor Code section 4600 to provide reasonable medical treatment by transferring an injured worker into an MPN in conformity with applicable statutes and regulations regardless of the date of injury or the date of an award of future medical treatment.” (Babbitt v. Ow Jing (2007) 72 Cal.Comp.Cases 70, 71 (Appeals Board en banc).)

Here SCIF argues that Claytor was brought back into the MPN when she selected Dr. Small as her PTP and thus, she may not now choose a non-MPN physician absent a denial of care.

To this argument the panel noted that if “Dr. Small is a member of defendant’s MPN (whether the old or new MPN), there may be a viable argument that applicant voluntarily returned herself to the MPN by selecting Dr. Small as her PTP and she may not now choose a PTP outside the MPN absent a denial of care. However, this conclusion presumes that Dr. Small is actually in the MPN, a fact that applicant has not conceded and is not supported by substantial evidence in the record.”

We do not presume Dr. Small is in the MPN based solely on defendant’s assertion that he is a member of it.

Defendant contends that applicant’s September 3, 2019 letter selecting Dr. Small as her PTP “should be sufficient for a finding that Dr. Small was in State Fund’s MPN at the time.”

“We disagree that applicant’s September 3, 2019 letter is sufficient to show that Dr. Small is in the MPN.” “Put simply, there is not substantial evidence showing that applicant was treating within the MPN when she requested to have Dr. Spencer resume his role as PTP. There is also no evidence in the record that defendant objected to applicant’s June 1, 2020 request to have Dr. Spencer act as her PTP again.”

There is substantial evidence to show years of treatment outside the MPN and no effective transfer of care returning applicant to treatment within the MPN. Under these circumstances, applicant is entitled to resume treatment with her non-MPN physician, Dr. Spencer, as her PTP.

However, the WCJ expressly found that defendant may return applicant to the MPN by complying with the statutory and regulatory requirements for transfer of care and continuity of care policies. Defendant must comply with the process outlined in AD Rule 9767.9(f) for transferring care.

The transfer of care provisions in Rule 9767.9(f) require defendant to make a determination regarding whether applicant’s condition satisfies – or fails to satisfy – one of the four conditions set forth in subsections (e)(1)-(4). This section requires that defendant determine whether applicant has a condition which would allow her to complete treatment with her PTP.

Furthermore, the regulation requires that defendant notify applicant of its determination regarding completion of care. This notification must also be sent to applicant’s PTP, be in English and Spanish, and use layperson’s terms to the maximum extent possible.

ChatGPT Answers Beat Physicians in JAMA Internal Medicine Study

The rapid expansion of virtual health care has caused a surge in patient messages concomitant with more work and burnout among health care professionals. The COVID-19 pandemic hastened the adoption of virtual health care, concomitant with a 1.6-fold increase in electronic patient messages, with each message adding 2.3 minutes of work in the electronic health record and more after-hours work.

As a result, some medical researchers began thinking that perhaps artificial intelligence (AI) assistants could potentially aid in creating answers to patient questions by drafting responses that could be reviewed by clinicians.

And they then proposed a study to evaluate the ability of an AI chatbot assistant (ChatGPT) to provide quality and empathetic responses to patient questions. The results were just published in the JAMA Internal Medicine.

In this cross-sectional study of 195 randomly drawn patient questions from a social media forum, a team of licensed health care professionals compared physician’s and chatbot’s responses to patient’s questions asked publicly on a public social media forum. The chatbot responses were preferred over physician responses and rated significantly higher for both quality and empathy.

Of the 195 questions and responses, evaluators preferred chatbot responses to physician responses in 78.6% of the 585 evaluations.

Mean physician responses were significantly shorter than chatbot responses. Chatbot responses were rated of significantly higher quality than physician responses. The proportion of responses rated as good or very good quality for instance, was higher for chatbot than physicians.

This amounted to 3.6 times higher prevalence of good or very good quality responses for the chatbot. Chatbot responses were also rated significantly more empathetic than physician responses. The proportion of responses rated empathetic or very empathetic was higher for chatbot than for physicians. This amounted to 9.8 times higher prevalence of empathetic or very empathetic responses for the chatbot.

Thus the researchers concluded that “Further exploration of this technology is warranted in clinical settings, such as using chatbot to draft responses that physicians could then edit. Randomized trials could assess further if using AI assistants might improve responses, lower clinician burnout, and improve patient outcomes.”

John W. Ayers, PhD, MA – one of the researchers – told MedPage Today. “I think of our study as a phase zero study, and it clearly shows that ChatGPT wins in a landslide compared to physicians, and I wouldn’t say we expected that at all.”

He said they were trying to figure out how ChatGPT, developed by OpenAI, could potentially help resolve the burden of answering patient messages for physicians, which he noted is a well-documented contributor to burnout.

Ayers said that he approached this study with his focus on another population as well, pointing out that the burnout crisis might be affecting roughly 1.1 million providers across the U.S., but it is also affecting about 329 million patients who are engaging with overburdened healthcare professionals.

“There are a lot of people out there asking questions that maybe go unanswered or get bad answers. What do we do to help them?” he said. “I think AI-assisted messaging could be a game changer for public health.

He noted that AI assistant messaging could change patient outcomes, and he wants to see more studies that focus on evaluating these outcomes. He said he hopes this study will motivate more research on this use of AI because of its potential to improve productivity and free up the time of clinical staff for more complex tasks.

Sedgwick Launches OpenAI GPT-4 Tools for Work Comp Claims

GPT stands for Generative Pre-trained Transformer (GPT), a type of language model that uses deep learning to generate human-like, conversational text.

ChatGPT is an artificial intelligence chatbot developed by OpenAI and released in November 2022. It works by gathering data (e.g.from the internet) written by people and using computing predictions to answer questions and queries inputted by the user. The latest version is GPT-4, which has been adopted by a number of companies, including Microsoft, Google, Facebook, Amazon, and IBM.

The technology is now the tool of choice for the intelligent digital worker that can work across pieces of software and data stores to automate increasingly sophisticated processes.

Earlier this year. it was reported that GPT-4 successfully passed the Uniform Bar Exam for prospective attorneys, with flying colors in every field and test segment, even outperforming the average human student.

And the technology is now on the doorstep of workers’ compensation claims.

Sedgwick has launched Sidekick, which they say is an industry-first integration using Microsoft’s OpenAI tools and services to give claims professionals an advantage in their daily work.

The application, which leverages OpenAI’s GPT-4 technology, is Sedgwick’s first use case of GPT. Designed for internal use within the company’s secure Azure environment,

Sidekick will allow Sedgwick colleagues to explore the impact of generative artificial intelligence (AI) performance and natural language processing on day-to-day tasks.

It joins Sedgwick’s existing set of tools powered by AI – including smart.ly, mySedgwick and viaOne – in transforming the way people interact with and leverage technology for better outcomes.

“Innovation is in our DNA,” said Mike Arbour, CEO of Sedgwick. “Sedgwick is proud to be first in the industry to utilize GPT not only for improved claims documentation, but to show how much we value the human touch. Sidekick is designed to supercharge our claims professionals – to help them move through some of the administrative tasks of claims management at speeds never before possible. Automating important but routine aspects of our work processes will help them gain value from information more quickly, relay it back to our clients efficiently, and dedicate more time to the people whose care is entrusted to them.”

As a first step, Sedgwick is integrating its industry-leading platforms already in use with Sidekick’s AI capabilities to promote claims document summarization, data classification and analysis. Initial examples of how colleagues can effectively work alongside Sidekick include:

– – Scanning PDF documents to produce automated content summaries, and easily adding the highlights to the appropriate claim file.
– – Utilizing the application to quickly uncover key data to help complete tasks and meaningfully impact claims.

Sedgwick anticipates future iterations of the application may be able to produce entire claim summaries, identify risk factors on individual claims and programs, explore emerging data trends, and more.

“As part of Sedgwick’s people first, tech forward and data driven approach to claims and productivity challenges, we are focused on three things,” said Jason Landrum, Sedgwick’s global chief information officer. “Communication and transforming the way we engage with people through different channels; automation of our processes and digitization of our tools; and innovation to leverage the latest advances in technology strategically but also securely. With Sidekick, we are leveraging evolving GPT technology for good – empowering the people who impact claims and finding ways to boost their engagement, job satisfaction and performance.”

With 2,000 dedicated IT resources and data scientists, Sedgwick says that it delivers superior technology-enabled solutions to many of the world’s premier employers and insurers. They say the company’s capabilities and systems are unparalleled, supporting virtually any kind of loss or claims program and prompting outstanding results: higher return on investment, decreased litigation, better understanding of customer concerns, faster resolution and improved overall satisfaction.

$1.47M Settlement Resolves Poultry Processor Wage Theft Citations

The Labor Commissioner’s Office has reached a $1.47 million settlement over wage theft citations issued against three client employers and their owner based on violations committed by five Los Angeles-area poultry processors who underpaid more than 300 workers.

The settlement resolves litigation following a 2021 hearing officer decision for $1.5 million which upheld citations against the three client employer companies (The Exclusive Poultry, Inc., J.T. Foods Specialty, Inc., and D8 Poultry, LLC) and owner Tony Bran.

California law holds client employers – businesses that obtain labor from a labor contractor – responsible for their contractors’ workplace violations. A client employer may be liable for owed wages, damages and penalties, as well as workers’ compensation violations.

“The law is clear: Employers must pay no less than the minimum wage for each hour worked, and compensate for rest periods and other non-productive time under the control of the employer,” said Labor Commissioner Lilia García-Brower. “This result also upholds the liability of client employers, who in this case built a business around low-paid processing workers and tried to hide behind undercapitalized labor contractors.”

The affected workers were paid by the piece to debone chicken legs at facilities in East Los Angeles and La Puente. They were not provided paid rest breaks as required by law, were not paid properly for overtime, and were not compensated for time required to wait for shipments of chicken to arrive and for deboned chicken to be removed from their work area. Some workers also made less than minimum wage. In addition, the poultry processors failed to maintain workers’ compensation coverage.

The Labor Commissioner’s Bureau of Field Enforcement (BOFE) began its investigation after a worker filed a complaint alleging wage violations in the summer of 2017. The investigation found that the poultry processors, operating in two facilities leased by client employer Tony Bran, paid workers a flat rate of $2.35 per 40-pound box of deboned chicken and failed to pay for rest breaks or other nonproductive time or overtime pay. Bran and his companies leased the processing facilities, supplied the chicken to be deboned, and sold the deboned chicken to their customers.

The poultry processors who directly employed the workers were Sullon Poultry, Inc. and Camacho Poultry, LLC, both in La Puente, and D-8 Foods, Inc., Best Poultry, Inc. and M.G Poultry, Inc., all in East Los Angeles. BOFE issued citations to the client employers in 2018 for the poultry processors’ labor law violations occurring between 2015 and 2018.

Bran and the three client employer companies he owns, The Exclusive Poultry, Inc., J.T. Foods Specialty, Inc., and D8 Poultry, LLC, appealed the citations. After a 10-day hearing, the hearing officer upheld the unpaid wages and penalties citations, with minor modifications, against Bran and his client employer companies. The hearing officer also determined that Bran and his companies were client employers to the five poultry processor labor contractors.

The October 2021 hearing officer decision found Bran and his companies responsible for the amounts due to workers and penalties for wage violations and for the failure to have workers’ compensation pursuant to California’s client-employer liability law. The hearing officer also found a total of $901,032 payable to workers in unpaid wages.

Bran and his companies were also found responsible for an additional $397,150 in civil penalties that were assessed for minimum wage, overtime, rest period and waiting time violations. The citations affirmed also include an additional $203,102 for workers’ compensation violations against Exclusive Poultry and Tony Bran. When workers are paid less than minimum wage, they are entitled to liquidated damages that equal the amount of underpaid minimum wages plus interest.

Following the hearing officer’s October 2021 decision, Bran and his client employer companies filed a request that the Los Angeles Superior Court review the decision. After the Labor Commissioner’s Office filed two lawsuits against Bran and four of his relatives alleging that Bran had transferred real estate to them to avoid paying for his legal liabilities, Bran and his client employer subsequently agreed to settle with the Labor Commissioner’s Office.

The Labor Commissioner’s Office has already received the $1.47 million settlement amount, and is in the process of locating affected workers to pay them the money they are owed.

New Federal Workers Comp Program OIG Audit Shows Epic Failure

The Department of Labor’s Office of Workers’ Compensation Programs (OWCP) provides workers’ compensation coverage to approximately 2.6 million federal and postal workers through the Federal Employees’ Compensation Act (FECA) program.

Back In Fiscal Year (FY) 2015 and FY 2016, a sharp increase in pharmaceutical spending for the FECA program raised concerns. Subsequent Office of Inspector General work found OWCP had not done enough to ensure it paid the best prices for prescription drugs, specifically noting the lack of a pharmacy benefit manager to help contain costs and the failure to determine if alternative prescription drug pricing methodologies would be more competitive.

In response, OWCP said it took a number of actions to reduce pharmaceutical spending, including implementing controls on prescriptions for compounded drugs and for opioids. According to data provided by OWCP, it significantly decreased total compounded drug spending from almost $256 million in FY 2016 to less than $176,000 in FY 2020 and reduced opioid spending from over $86 million in FY 2016 to approximately $29 million in FY 2020.5

However, the Office of Inspector General remained concerned about OWCP’s ability to effectively manage the cost, as well as the use, of pharmaceuticals in the FECA program.

Given these concerns, U.S. Office of Inspector General recently contracted with the independent certified public accounting firm of Harper, Rains, Knight & Company, P.A. (HRK) to conduct an audit to determine if OWCP had indeed effectively managed pharmaceutical spending in the FECA program since the 2015-2016 audit.

To answer this question, HRK’s audit included: analyzing 6 years of pharmaceutical data covering Fiscal Year 2015 through Fiscal Year 2020; interviewing OWCP management; reviewing OWCP policies, procedures, and other documentation; and comparing the FECA program to industry best practices and other workers’ compensation programs.

The March 2023 Office of Inspector General audit report found that OWCP did not effectively manage pharmaceutical spending in the FECA program from Fiscal Year 2015 through Fiscal Year 2020. Specifically, OWCP did not pay the best available prices for prescription drugs. HRK identified up to $321.26 million in excess spending during the audit period.

In addition, OWCP did not effectively monitor pharmaceutical policy changes to ensure implementation, resulting in claimants receiving thousands of inappropriate prescriptions and potentially lethal drugs, including 1,330 prescriptions for fast-acting fentanyl after issuing a policy that restricted its use.

HRK also found OWCP failed to timely identify and address emerging issues and did not perform sufficient oversight of prescription drugs that are highly scrutinized and rarely covered in workers’ compensation programs. As a result, OWCP spent hundreds of millions of dollars on drugs that may not have been necessary or appropriate for FECA claimants.

Finally, HRK found OWCP lacked sufficient clinical expertise and guidelines to ensure appropriate pharmaceutical decisions, which could negatively impact claimants’ health, recovery, and return to work.

Remarkably the current audit noted that “Health Affairs, a peer-reviewed journal of health policy that has been cited by government officials and national media, reported that prescription drug rebates can sometimes reach 50 percent or more of list price and total Medicare Part D drug spending offset by rebates on brand name drugs in 2018 was 25 percent.”

Even though incorporating rebates can result in substantial savings, OWCP indicated it did not incorporate prescription drug manufacturer rebates in the FECA pharmaceutical program. According to OWCP officials, the FECA program never had a mechanism, or a contract, to incorporate rebates for pharmacy expenditures during the audit period.”

On the topic of appropriate prescriptions, the new audit continued to say that “OWCP issued significant policy and process changes related to claimant prescriptions prior to and during the audit period. Although these changes were intended to improve claimant safety and save costs, OWCP did not ensure the changes were properly implemented.”

“This occurred because OWCP did not effectively monitor its bill pay vendor, who was responsible for implementing these changes. As a result, OWCP allowed claimants to receive thousands of inappropriate prescriptions and potentially lethal drugs, which could have caused serious harm to claimants.”

For example, OWCP paid for more than 98 percent (1,330 of 1,348) of prescriptions for fast-acting fentanyl, a potentially lethal and extremely addictive drug, without evidence of required cancer diagnoses.”

HRK made 10 recommendations to OWCP to strengthen management of pharmaceuticals in the FECA program, specifically regarding: evaluating alternate pricing methodologies, ensuring implementation of and adherence to policies, identifying emerging issues by developing and implementing an ongoing pharmaceutical monitoring program, ensuring sufficient clinical expertise among FECA staff, and using evidence-based clinical guidelines to inform prescription drug coverage policies.

OWCP generally agreed with the latest recommendations.